Literature DB >> 27113046

Persistent Increase in Blood Pressure After Renal Nerve Stimulation in Accessory Renal Arteries After Sympathetic Renal Denervation.

Mark R de Jong1, Annemiek F Hoogerwaard1, Pim Gal1, Ahmet Adiyaman1, Jaap Jan J Smit1, Peter Paul H M Delnoy1, Anand R Ramdat Misier1, Boudewijn A A M van Hasselt1, Jan-Evert Heeg1, Jean-Benoit le Polain de Waroux1, Elizabeth O Y Lau1, Jan A Staessen1, Alexandre Persu1, Arif Elvan2.   

Abstract

Blood pressure response to renal denervation is highly variable, and the proportion of responders is disappointing. This may be partly because of accessory renal arteries too small for denervation, causing incomplete ablation. Renal nerve stimulation before and after renal denervation is a promising approach to assess completeness of renal denervation and may predict blood pressure response to renal denervation. The objective of the current study was to assess renal nerve stimulation-induced blood pressure increase before and after renal sympathetic denervation in main and accessory renal arteries of anaesthetized patients with drug-resistant hypertension. The study included 21 patients. Nine patients had at least 1 accessory renal artery in which renal denervation was not feasible. Renal nerve stimulation was performed in the main arteries of all patients and in accessory renal arteries of 6 of 9 patients with accessory arteries, both before and after renal sympathetic denervation. Renal nerve stimulation before renal denervation elicited a substantial increase in systolic blood pressure, both in main (25.6±2.9 mm Hg; P<0.001) and accessory (24.3±7.4 mm Hg; P=0.047) renal arteries. After renal denervation, renal nerve stimulation-induced systolic blood pressure increase was blunted in the main renal arteries (Δ systolic blood pressure, 8.6±3.7 mm Hg; P=0.020), but not in the nondenervated renal accessory renal arteries (Δ systolic blood pressure, 27.1±7.6 mm Hg; P=0.917). This residual source of renal sympathetic tone may result in persistent hypertension after ablation and partly account for the large response variability.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  accessory renal artery; blood pressure; denervation; hypertension; hypertension resistant to conventional therapy; renal artery; renal nerve stimulation

Mesh:

Substances:

Year:  2016        PMID: 27113046     DOI: 10.1161/HYPERTENSIONAHA.115.06604

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

1.  Aorticorenal Ganglia Pacing: A Step Forward in Unblinding Renal Denervation Procedures?

Authors:  Felix Mahfoud; Thomas Tschernig; Elazer R Edelman
Journal:  JACC Cardiovasc Interv       Date:  2019-06-24       Impact factor: 11.195

Review 2.  Resistant Hypertension: An Update of Experimental and Clinical Findings.

Authors:  Anping Cai; David A Calhoun
Journal:  Hypertension       Date:  2017-05-15       Impact factor: 10.190

Review 3.  Selective vs. Global Renal Denervation: a Case for Less Is More.

Authors:  Marat Fudim; Asher A Sobotka; Yue-Hui Yin; Joanne W Wang; Howard Levin; Murray Esler; Jie Wang; Paul A Sobotka
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

Review 4.  Catheter-Based Renal Nerve Ablation as a Novel Hypertension Therapy: Lost, and Then Found, in Translation.

Authors:  John W Osborn; Christopher T Banek
Journal:  Hypertension       Date:  2018-01-02       Impact factor: 10.190

Review 5.  Patient Selection for Renal Denervation in Hypertensive Patients: What Makes a Good Candidate?

Authors:  Sheran Li; Jacqueline K Phillips
Journal:  Vasc Health Risk Manag       Date:  2022-05-13

Review 6.  Renal Nerve Stimulation as Procedural End Point for Renal Sympathetic Denervation.

Authors:  Annemiek F Hoogerwaard; Mark R de Jong; Arif Elvan
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

Review 7.  ConfidenHT™ System for Diagnostic Mapping of Renal Nerves.

Authors:  Costas Tsioufis; Kyriakos Dimitriadis; Panagiotis Tsioufis; Rafael Patras; Maria Papadoliopoulou; Zoi Petropoulou; Dimitris Konstantinidis; Dimitrios Tousoulis
Journal:  Curr Hypertens Rep       Date:  2018-05-19       Impact factor: 5.369

8.  Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation.

Authors:  Mark R de Jong; Annemiek F Hoogerwaard; Ahmet Adiyaman; Jaap Jan J Smit; Anand R Ramdat Misier; Jan-Evert Heeg; Boudewijn A A M van Hasselt; Isabelle C Van Gelder; Harry J G M Crijns; Ignacio Fernández Lozano; Jorge E Toquero Ramos; F Javier Alzueta; Borja Ibañez; José M Rubio; Fernando Arribas; José M Porres Aracama; Josep Brugada; Lluís Mont; Arif Elvan
Journal:  Clin Res Cardiol       Date:  2018-02-27       Impact factor: 5.460

9.  Quantitative analysis of renal arterial variations affecting the eligibility of catheter-based renal denervation using multi-detector computed tomography angiography.

Authors:  Won Hoon Song; Jinhwan Baik; Eue-Keun Choi; Hae-Young Lee; Hyeon Hoe Kim; Sung-Min Park; Chang Wook Jeong
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

Review 10.  Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium.

Authors:  Kazuomi Kario; Byeong-Keuk Kim; Jiro Aoki; Anthony Yiu-Tung Wong; Ying-Hsiang Lee; Nattawut Wongpraparut; Quang Ngoc Nguyen; Wan Azman Wan Ahmad; Soo Teik Lim; Tiong Kiam Ong; Tzung-Dau Wang
Journal:  Hypertension       Date:  2020-02-03       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.